Daiichi-Sankyo (Japan)

Daiichi-Sankyo (Japan)

Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 981.8 billion in revenue in 2019. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Daiichi-Sankyo (Japan), Japan, covering academic research published from 2000 to 2022. Read More.


Open Access Percentage

47%


Total
Publications

4.2K


Total Open
Publications

2K


Total
Citations

102K


Open Access
Percentage

47%


Total
Publications

4.2K


Total Open
Publications

2K


Total
Citations

102K

Wikipedia

Website

download

Breakdown

25% 17% 5% 53%

Publisher Open

25%

Both

17%

Other Platform Open

5%

Closed

53%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

050100150200250300Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Open

Closed

Publisher Open

21%OA Journal

OA Journal 21%

363

Hybrid 34%

607

No Guarantees 45%

792

Other Platform Open

Domain 84%

787

Institution 19%

180

Public 14%

135

Other Internet 7%

70

Preprint 4%

38

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
783
Europe PMC
Domain
526
Figshare
Public
107
Semantic Scholar
Public
97
DOI
Other Internet
79
Research Square
Preprint
23
University of Birmingham - University of Birmingham Research Portal
Institution
22
California Digital Library - eScholarship
Other Internet
16
Kyoto University - Kyoto University Research Information Repository
Institution
14
bioRxiv
Preprint
14
1 / 13

Data updated 15 November 2023

Share

Share

Share